Tubo-ovarian abscess: Difference between revisions

(Text replacement - "OR" to "'''OR'''")
Line 40: Line 40:


===Inpatient===
===Inpatient===
*[[Cefoxitin]] 2gm IV q6hr OR [[cefotetan]] 2gm IV q12hr) + [[doxycycline]] PO or IV 100mg q12hr OR
*[[Cefoxitin]] 2gm IV q6hr '''OR''' [[cefotetan]] 2gm IV q12hr) + [[doxycycline]] PO or IV 100mg q12hr '''OR'''
*[[Clindamycin]] 900mg IV q8h + [[gentamicin]] 2mg/kg QD OR
*[[Clindamycin]] 900mg IV q8h + [[gentamicin]] 2mg/kg QD '''OR'''
*[[Ampicillin-sulbactam]] 3gm IV q6hr + [[doxycycline]] 100mg IV/PO q12hr
*[[Ampicillin-sulbactam]] 3gm IV q6hr + [[doxycycline]] 100mg IV/PO q12hr



Revision as of 01:06, 31 May 2017

Background

Risk factors

  • Multiple sex partners
  • Age 15-25 years old
  • Prior history of PID
  • IUD
  • HIV infection

Clinical Features

  • +/-Fever
  • Vaginal discharge
  • Dyspareunia
  • Disproportionate unilateral adnexal tenderness or adnexal mass or fullness
  • Suspect in patient who does not respond after 72hr of treatment for PID

Differential Diagnosis

Acute Pelvic Pain

Differential diagnosis of acute pelvic pain

Gynecologic/Obstetric

Genitourinary

Gastrointestinal

Musculoskeletal

Vascular

Evaluation

  • CBC
  • ESR/CRP
  • TVUS (Sn 75-82%)
or
  • CT pelvis (Sn 78-100%)
    • Preferred with patients in whom associated GI pathology must be excluded

Management

  • OB/GYN consult
  • Majority (60-80%) resolve with antibiotics alone

Outpatient

Inpatient

Disposition

  • Decision should be made in conjunction with gynecological colleague
  • Patient with fevers, elevated WBC, abscess greater than 5 cm, or systemic toxicity demand admission
  • Hemodynamically stable, afebrile patients with a relatively small abscess can be safely discharged with close gynecological follow up on antibiotics

See Also

References

  1. Norris DL, Young JD. UTI. EM Clin N Am. 2008; 26:413-30.